NCT06565611 A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06534411 A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06518837 Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer Status RECRUITING Phase PHASE2
NCT06515418 Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over Status TERMINATED Phase PHASE2
NCT06485089 Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06445075 Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese Status COMPLETED Phase PHASE2
NCT06439277 A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2) Status RECRUITING Phase PHASE3
NCT06373146 A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity Status COMPLETED Phase PHASE2
NCT06354101 The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study. Status WITHDRAWN Phase N/A
NCT06326060 A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight Status COMPLETED Phase PHASE2
NCT06301256 Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis Suppurativa Status NOT_YET_RECRUITING Phase NA
NCT06297616 A Study of LY3841136 in Japanese Participants With Obesity or Overweight Status COMPLETED Phase PHASE1
NCT06246799 Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes Status RECRUITING Phase PHASE3
NCT06221969 A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor Status COMPLETED Phase PHASE3
NCT06191848 Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA) Status RECRUITING Phase PHASE4
NCT06180616 Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity Status NOT_YET_RECRUITING Phase PHASE2
NCT06162715 GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial Status ENROLLING_BY_INVITATION Phase PHASE2/PHASE3